Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
about
CIViC databaseJAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics.Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia.Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells.Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents.Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP.In vitro analysis of microRNA-26a in chronic lymphocytic leukemia cells
P2860
Q27612411-9C00BCE0-925F-46E7-8E6A-91A8DD5E4104Q35635353-6F40DEDC-E704-4994-B7FA-4BF328E0B22EQ37109225-32B0BC32-1583-4505-BB72-EDE355CAEA1BQ37605160-2C14D385-D802-4059-8BF6-BE4FF352248FQ38309479-99975B4D-2649-474E-B15C-68D3B5C6F0E8Q38848675-2A4F0137-9574-462C-BB89-96FE15ECEBBDQ40357233-22D96F18-694C-4D0A-8E3C-DFDB25514428Q40614547-0833B583-BE2A-486B-835B-3C2BFF589BDCQ42380473-A2434749-2493-4408-A60A-B29EE5990DD3Q46128404-C67F209B-05CC-4415-B3D1-7FCAEC2011EBQ57478265-308C2A71-E091-436C-8770-320E0EDEE8C7
P2860
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@ast
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@en
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@nl
type
label
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@ast
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@en
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@nl
prefLabel
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@ast
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@en
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@nl
P2860
P356
P1433
P1476
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.
@en
P2093
Kapil Bhalla
Ramadevi Nimmanapalli
P2860
P2888
P304
P356
10.1038/SJ.ONC.1206086
P407
P577
2002-12-09T00:00:00Z
P6179
1040526153